- TRUE HUMAN™
- CORPORATE STRATEGY
Global sales of psoriasis drugs were estimated at $3.9 billion in 2010. These sales are expected to grow to over $7 billion by 2020. Sales projections are based on growth in the major markets of the US, Europe and Japan. Further market penetration and new therapies are expected to underlie growth in this sector. XBiotech believes that safety and affordability of new therapies will also be key factors in market performance.
© 2012 XBiotech USA, Inc. | All Rights Reserved